Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 702 word(s) 702 2020-12-15 07:21:38

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Yin, N. DOCK8 Immunodeficiency Syndrome. Encyclopedia. Available online: (accessed on 18 April 2024).
Yin N. DOCK8 Immunodeficiency Syndrome. Encyclopedia. Available at: Accessed April 18, 2024.
Yin, Nicole. "DOCK8 Immunodeficiency Syndrome" Encyclopedia, (accessed April 18, 2024).
Yin, N. (2020, December 24). DOCK8 Immunodeficiency Syndrome. In Encyclopedia.
Yin, Nicole. "DOCK8 Immunodeficiency Syndrome." Encyclopedia. Web. 24 December, 2020.
DOCK8 Immunodeficiency Syndrome

DOCK8 immunodeficiency syndrome is a disorder of the immune system. The condition is characterized by recurrent infections that are severe and can be life-threatening. The infections can be caused by bacteria, viruses, or fungi. Skin infections cause rashes, blisters, accumulations of pus (abscesses), open sores, and scaling. People with DOCK8 immunodeficiency syndrome also tend to have frequent bouts of pneumonia and other respiratory tract infections. Other immune system-related problems in people with DOCK8 immunodeficiency syndrome include an inflammatory skin disorder called eczema, food or environmental allergies, and asthma.

genetic conditions

1. Introduciton

DOCK8 immunodeficiency syndrome is characterized by abnormally high levels of an immune system protein called immunoglobulin E (IgE) in the blood; the levels can be more than 10 times higher than normal for no known reason. IgE normally triggers an immune response against foreign invaders in the body, particularly parasitic worms, and plays a role in allergies. It is unclear why people with DOCK8 immunodeficiency syndrome have such high levels of this protein. People with DOCK8 immunodeficiency syndrome also have highly elevated numbers of certain white blood cells called eosinophils (hypereosinophilia). Eosinophils aid in the immune response and are involved in allergic reactions.

Some people with DOCK8 immunodeficiency syndrome have neurological problems, such as paralysis that affects the face or one side of the body (hemiplegia). Blockage of blood flow in the brain or abnormal bleeding in the brain, both of which can lead to stroke, can also occur in DOCK8 immunodeficiency syndrome.

People with DOCK8 immunodeficiency syndrome have a greater-than-average risk of developing cancer, particularly cancers of the blood or skin.

DOCK8 immunodeficiency syndrome is also commonly called autosomal recessive hyper-IgE syndrome. However, researchers have identified several conditions that feature elevated levels of IgE and that follow an autosomal recessive pattern of inheritance. Each of these conditions has its own set of additional signs and symptoms and a different genetic cause. Some doctors consider these conditions forms of hyper-IgE syndrome, while others consider them independent disorders.

2. Frequency

DOCK8 immunodeficiency syndrome is a rare disorder whose prevalence is unknown.

3. Causes

DOCK8 immunodeficiency syndrome is caused by mutations in the DOCK8 gene. The protein produced from this gene plays a critical role in the survival and function of several types of immune system cells. One of the functions of the DOCK8 protein is to help maintain the structure and integrity of immune cells called T cells and NK cells, which recognize and attack foreign invaders, particularly as these cells travel to sites of infection within the body. In addition, the DOCK8 protein is involved in chemical signaling pathways that stimulate other immune cells called B cells to mature and produce antibodies, which are specialized proteins that attach to foreign particles and germs, marking them for destruction.

DOCK8 gene mutations result in the production of little or no functional DOCK8 protein. Shortage of this protein impairs normal immune cell development and function. It is thought that T cells and NK cells lacking DOCK8 protein are abnormal and die too easily, particularly when moving through the layers of skin. A shortage of these immune cells impairs the immune response to foreign invaders, accounting for the severe skin infections common in DOCK8 immunodeficiency syndrome. A lack of DOCK8 protein also impairs B cell maturation and the production of antibodies. Impairment of this type of immune response leads to recurrent respiratory tract infections in people with this disorder. It is unclear how DOCK8 gene mutations are involved in other features of DOCK8 immunodeficiency syndrome, such as the elevation of IgE levels, and neurological problems.

4. Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

5. Other Names for This Condition

  • autosomal recessive HIES
  • autosomal recessive hyper-IgE syndrome
  • CID due to DOCK8 deficiency
  • combined immunodeficiency due to DOCK8 deficiency
  • DOCK8 deficiency
  • hyper IgE recurrent infection syndrome, autosomal recessive
  • hyper immunoglobulin E syndrome, autosomal recessive
  • hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive
  • hyperimmunoglobulin E syndrome type 2
  • non-skeletal hyper-IgE syndrome


  1. Engelhardt KR, Gertz ME, Keles S, Schäffer AA, Sigmund EC, Glocker C, Saghafi S, Pourpak Z, Ceja R, Sassi A, Graham LE, Massaad MJ, Mellouli F, Ben-Mustapha I,Khemiri M, Kilic SS, Etzioni A, Freeman AF, Thiel J, Schulze I, Al-Herz W, Metin A, Sanal Ö, Tezcan I, Yeganeh M, Niehues T, Dueckers G, Weinspach S, Patiroglu T,Unal E, Dasouki M, Yilmaz M, Genel F, Aytekin C, Kutukculer N, Somer A, Kilic M, Reisli I, Camcioglu Y, Gennery AR, Cant AJ, Jones A, Gaspar BH, Arkwright PD,Pietrogrande MC, Baz Z, Al-Tamemi S, Lougaris V, Lefranc G, Megarbane A, Boutros J, Galal N, Bejaoui M, Barbouche MR, Geha RS, Chatila TA, Grimbacher B. Theextended clinical phenotype of 64 patients with dedicator of cytokinesis 8deficiency. J Allergy Clin Immunol. 2015 Aug;136(2):402-12. doi:10.1016/j.jaci.2014.12.1945.
  2. Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, ChenA, Kim HS, Lloret MG, Schulze I, Ehl S, Thiel J, Pfeifer D, Veelken H, Niehues T,Siepermann K, Weinspach S, Reisli I, Keles S, Genel F, Kutukculer N, Camcioğlu Y,Somer A, Karakoc-Aydiner E, Barlan I, Gennery A, Metin A, Degerliyurt A,Pietrogrande MC, Yeganeh M, Baz Z, Al-Tamemi S, Klein C, Puck JM, Holland SM,McCabe ER, Grimbacher B, Chatila TA. Large deletions and point mutationsinvolving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009 Dec;124(6):1289-302.e4. doi: 10.1016/j.jaci.2009.10.038. Erratum in: J Allergy Clin Immunol. 2010Mar;125(3):743. Kutuculer, Necil [corrected to Kutukculer, Necil].
  3. Jabara HH, McDonald DR, Janssen E, Massaad MJ, Ramesh N, Borzutzky A, RauterI, Benson H, Schneider L, Baxi S, Recher M, Notarangelo LD, Wakim R, Dbaibo G,Dasouki M, Al-Herz W, Barlan I, Baris S, Kutukculer N, Ochs HD, Plebani A,Kanariou M, Lefranc G, Reisli I, Fitzgerald KA, Golenbock D, Manis J, Keles S,Ceja R, Chatila TA, Geha RS. DOCK8 functions as an adaptor that links TLR-MyD88signaling to B cell activation. Nat Immunol. 2012 May 13;13(6):612-20. doi:10.1038/ni.2305.
  4. Mizesko MC, Banerjee PP, Monaco-Shawver L, Mace EM, Bernal WE,Sawalle-Belohradsky J, Belohradsky BH, Heinz V, Freeman AF, Sullivan KE, Holland SM, Torgerson TR, Al-Herz W, Chou J, Hanson IC, Albert MH, Geha RS, Renner ED,Orange JS. Defective actin accumulation impairs human natural killer cellfunction in patients with dedicator of cytokinesis 8 deficiency. J Allergy ClinImmunol. 2013 Mar;131(3):840-8. doi: 10.1016/j.jaci.2012.12.1568.
  5. Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, Bergmann M,Davis J, Belohradsky BH, Grimbacher B. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004 Jan;144(1):93-9.
  6. Su HC, Jing H, Angelus P, Freeman AF. Insights into immunity from clinical andbasic science studies of DOCK8 immunodeficiency syndrome. Immunol Rev. 2019Jan;287(1):9-19. doi: 10.1111/imr.12723. Review.
  7. Zhang Q, Dove CG, Hor JL, Murdock HM, Strauss-Albee DM, Garcia JA, Mandl JN,Grodick RA, Jing H, Chandler-Brown DB, Lenardo TE, Crawford G, Matthews HF,Freeman AF, Cornall RJ, Germain RN, Mueller SN, Su HC. DOCK8 regulates lymphocyteshape integrity for skin antiviral immunity. J Exp Med. 2014 Dec15;211(13):2549-66. doi: 10.1084/jem.20141307.
  8. Zhang Q, Jing H, Su HC. Recent Advances in DOCK8 Immunodeficiency Syndrome. J Clin Immunol. 2016 Jul;36(5):441-9. doi: 10.1007/s10875-016-0296-z.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 262
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020